 - Patients who have had radiation therapy, hormonal therapy, biologic therapy, or chemotherapy for cancer within the 21 days prior to Day 1 of the study. Patients with prostate cancer who are already receiving androgen deprivation therapy ie. leuprolide or goserelin for longer than 3 months may continue on this therapy during the study. 